Cardiovascular magnetic resonance imaging techniques established clinically have advanced the sequential assessment of cardiac fibrosis in experimental mouse models, facilitating reverse translation.
This review highlights the technical advancements in CMR for assessing cardiac fibrosis in mouse models, emphasizing its role in reverse translation and the discovery of anti-fibrotic therapies.
Cardiovascular magnetic resonance (CMR) imaging has become an essential technique for the assessment of cardiac function and morphology, and is now routinely used to monitor disease progression and intervention efficacy in the clinic. Cardiac fibrosis is a common characteristic of numerous cardiovascular diseases and often precedes cardiac dysfunction and heart failure. Hence, the detection of cardiac fibrosis is important for both early diagnosis and the provision of guidance for interventions/therapies. Experimental mouse models with genetically and/or surgically induced disease have been widely used to understand mechanisms underlying cardiac fibrosis, and to assess new treatment strategies. Improving the appropriate applications of CMR to mouse studies of cardiac fibrosis has the potential to generate new knowledge, and more accurately examine the safety and efficacy of anti-fibrotic therapies. In this review, we provide 1) a brief overview of different types of cardiac fibrosis, 2) general background on magnetic resonance imaging (MRI), 3) a summary of different CMR techniques used in mice for the assessment of cardiac fibrosis including experimental and technical considerations (contrast agents and pulse sequences), and 4) provide an overview of mouse studies that have serially monitored cardiac fibrosis during disease progression and/or therapeutic interventions. Clinically established CMR protocols have advanced mouse CMR for the detection of cardiac fibrosis, and there is hope that discovery studies in mice will identify new anti-fibrotic therapies for patients; highlighting the value of both reverse translation and bench-to-bedside research.
Chen et al. (Fri,) conducted a review in Cardiac fibrosis. Cardiovascular magnetic resonance (CMR) imaging was evaluated. Cardiovascular magnetic resonance imaging techniques established clinically have advanced the sequential assessment of cardiac fibrosis in experimental mouse models, facilitating reverse translation.